Cargando…
Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma
Mucin 1 (MUC1), as an oncogene, is overexpressed in hepatocellular carcinoma (HCC) cells and promotes the progression and tumorigenesis of HCC through JNK/TGF‐β signaling pathway. In the present study, RNA interference (RNAi) and JNK inhibitor SP600125, which target MUC1 and/or JNK, were used to tre...
Autores principales: | Wang, Juan, Ni, Wei‐hua, Hu, Ke‐bang, Zhai, Xiao‐yu, Xie, Fei, Jie, Jing, Zhang, Nan‐nan, Jiang, Li‐na, Yuan, Hong‐yan, Tai, Gui‐xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378288/ https://www.ncbi.nlm.nih.gov/pubmed/28012230 http://dx.doi.org/10.1111/cas.13144 |
Ejemplares similares
-
The Combination of MBP and BCG-Induced Dendritic Cell Maturation through TLR2/TLR4 Promotes Th1 Activation In Vitro and Vivo
por: Jiang, LiNa, et al.
Publicado: (2017) -
Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions
por: Wang, Juan, et al.
Publicado: (2015) -
Expression of MUC1 and MUC4 in Gallbladder Adenocarcinoma
por: Kim, Su-Mi, et al.
Publicado: (2012) -
PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer
por: Zhuang, Juhua, et al.
Publicado: (2019) -
Carbocisteine inhibits the expression of Muc5b in COPD mouse model
por: Song, Yan, et al.
Publicado: (2019)